Prodromal Signs and Symptoms of Serious Infections With Tocilizumab Treatment for Rheumatoid Arthritis: Text Mining of the Japanese Postmarketing Adverse Event-Reporting Database

Modern Rheumatology - United Kingdom
doi 10.1080/14397595.2017.1366007
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Effectiveness and Safety of Tocilizumab: Postmarketing Surveillance of 7901 Patients With Rheumatoid Arthritis in Japan

Journal of Rheumatology
RheumatologyAllergyImmunology
2013English

Immunotherapy of Tocilizumab for Rheumatoid Arthritis

Journal of Clinical & Cellular Immunology
2013English

Safety of Biologics Approved for the Treatment of Rheumatoid Arthritis and Other Autoimmune Diseases: A Disproportionality Analysis From the FDA Adverse Event Reporting System (FAERS)

BioDrugs
MedicineBiotechnologyPharmacology
2018English

Serious Adverse Drug Events Reported to the Food and Drug Administration (FDA): Analysis of the FDA Adverse Event Reporting System (FAERS) 2006-2011 Database

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2015English

Incidence of Gastrointestinal Perforations in Patients With Rheumatoid Arthritis Treated With Tocilizumab From Clinical Trial, Postmarketing, and Real-World Data Sources

Rheumatology and Therapy
2016English

Prm87 - Critical Evaluation of Various Data Mining Algorithms Used for Signal Detection in Fda Adverse Event Reporting System Database

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Long-Term Safety and Effectiveness of Adalimumab for the Treatment of Japanese Patients With Rheumatoid Arthritis: 3-Year Results From a Postmarketing Surveillance of 552 Patients

Modern Rheumatology
MedicineRheumatology
2017English

Tocilizumab, a Humanized Anti-Interleukin-6 Receptor Antibody, for Treatment of Rheumatoid Arthritis

Open Access Rheumatology: Research and Reviews
Rheumatology
2011English

Analysis of Adverse Events Associated With the Anti-Allergic Agents Rx-To-Otc-Switched Using Data Mining of the Japanese Adverse Drug Event Report (JADER) Database

Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences)
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy